Infliximab Children | Predicting Reaction | Medical Algorithm

Evaluation

Are you evaluating a pediatric patient receiving an infliximab infusion?

Yes

Gender of the patient

Male

Female

Number of previous infusions of infliximab

Has the patient had a medically significant infusion reaction before?

Yes

Is the patient receiving immunosuppressive therapy?

Yes

Number of months on immunosuppressive therapy

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Number of risk factors for an infusion reaction

Is the patient at risk for a medically significant reaction to infliximab?

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
- When to Suspect the Formation of Anti-Infliximab Antibodies in a Patient
Laboratory Tests
- When to Suspect the Formation of Anti-Infliximab Antibodies in a Patient

Therapy

Drug Interactions
- When to Suspect the Formation of Anti-Infliximab Antibodies in a Patient
- Immune Reconstitution Inflammatory Syndrome (IRIS)

Monitoring

Response To Therapy
- Immune Reconstitution Inflammatory Syndrome (IRIS)
Adverse Effects
- Contraindications for Use of Infliximab
- Immune Reconstitution Inflammatory Syndrome (IRIS)
Complication Detection
- Contraindications for Use of Infliximab

Specialty

Pharmacology, clinical

Objective

risk factors
adverse effects

ICD-10

T39.9 - Poisoning, nonopioid analgesic, antipyretic and antirheumatic, unspecified

Infusion of Infliximab | Predicting a Reaction in Pediatric Patients

Purpose: To determine if a pediatric patient receiving an infliximab infusion is likely to have a medically significant reaction.